Is Phio Pharmaceuticals Corp (PHIO) overvalued? · $10.4M cap
Phio Pharmaceuticals Corp (PHIO) is a biotechnology company listed on US.
This page asks whether Phio Pharmaceuticals Corp (PHIO) looks expensive on cached numbers — not a short thesis.
No cached income statement for PHIO, so there is no earnings base to call rich or cheap.
PHIO currently screens at market cap $10.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PHIO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PHIO stock page for the full model, not this heading.
Not investment advice.